sterile_file
TL3 Regular · Wolverhampton, UK
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 20 November 2024 · last posted 23h · groups: analytical-chemists
125 posts, newest first. Showing up to 150.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #57 · Pharmacology › Receptor biology · 27 Jul 2026 · 6 likes The strongest argument against my own position on receptor desensitisation, stated as well as I can state it, since nobody else has yet.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #73 · Sourcing › Regulatory · 25 Jul 2026 · 0 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here. I would call that likely…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #52 · Compounds › Repair & healing peptides · 25 Jul 2026 · 1 like Post #48 put the caveat in the right place and I want to underline it. The absence of adequately powered published randomised human trials is the central fact about…
-
Sleep quality changes during weight loss Replied, post #28 · Wellbeing › Sleep · 24 Jul 2026 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
-
Request: a per-category review queue Replied, post #119 · Meta › Feature requests · 21 Jul 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #96 · Analytics › Impurities & related substances · 20 Jul 2026 · 0 likes I read post #95 twice before replying, because I had assumed the opposite. The honest reading of a purity figure: it is an upper bound on how much of what the method…
-
Conditions that change the calculus rather than forbidding it Replied, post #30 · Safety › Contraindications · 15 Jul 2026 · 0 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. Conditions: I have looked for the primary source twice and failed twice. Either it…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #90 · Sourcing › Independent verification · 14 Jul 2026 · 14 likes Worth separating two things that post #88 runs together. Where two services agree with each other and with the declared figure, that is a genuinely strong result and it…
-
Revisiting: What pooling buys you and what it destroys Replied, post #90 · Evidence › Meta-analyses · 13 Jul 2026 · 12 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
What changed in 2026, by region — does this still hold? Replied, post #22 · Access › International · 12 Jul 2026 · 9 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #55 · Practice › Administration · 11 Jul 2026 · 0 likes Pinch is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #3 · Start Here › How to Ask · 7 Jul 2026 · 22 likes The opening post is right about the mechanism and I think understates the practical bit. The specific question in the title is more useful than you might think. A title…
-
Athletes in weight-category sports: a different risk calculus Replied, post #15 · Clinical › Special populations · 6 Jul 2026 · 22 likes The practical version of athletes in weight-category sports is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Follow-up: Interpreting a composition change that is within the error bars Replied, post #3 · marked as the solution · Outcomes › Body composition · 4 Jul 2026 · 6 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #83 · Compounds › Repair & healing peptides · 2 Jul 2026 · 5 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Common supplements people ask about, assessed one at a time Replied, post #4 · Practice › Interactions · 2 Jul 2026 · 13 likes Thank you for the correction. I would rather find out here than later.
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2026 · 0 likes Post #10 put the caveat in the right place and I want to underline it. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or…
-
Alcohol: what is documented and what is folklore Replied, post #74 · Practice › Interactions · 24 Jun 2026 · 14 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
-
Insurance and replacement policies, compared Replied, post #24 · Sourcing › Logistics · 16 Jun 2026 · 3 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #35 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 23 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Pooling trials with different estimands Replied, post #17 · Evidence › Meta-analyses · 10 Jun 2026 · 22 likes Pooling trials with different estimands was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a…
-
What changed in 2026, by region — does this still hold? Replied, post #13 · Access › International · 5 Jun 2026 · 9 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. Someone…
-
Blind submission and why it changes minds — the long version Replied, post #111 · Sourcing › Independent verification · 1 Jun 2026 · 0 likes Adding a null result on Blind submission. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Bioimpedance and hydration: why the number moves Replied, post #50 · Outcomes › Body composition · 25 May 2026 · 2 likes Source for the bioimpedance and hydration figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
Alcohol: what is documented and what is folklore Replied, post #23 · Practice › Interactions · 22 May 2026 · 32 likes The reason alcohol is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #76 · Compounds › Tirzepatide · 22 May 2026 · 1 like SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Search filters: what is missing Replied, post #60 · Meta › Site feedback · 22 May 2026 · 8 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
How much fluid is actually needed, and how you would know Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 21 May 2026 · 23 likes Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem. It is worth checking rather…
-
How to ask about something you suspect is a bad idea Replied, post #88 · Start Here › How to Ask · 14 May 2026 · 16 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Private prescribing in the UK: what is actually involved Replied, post #10 · Regional › UK & Ireland · 6 May 2026 · 15 likes Where I part company with post #9, and it is a narrow parting. I would call the community position on private prescribing likely rather than established, and I would be…
-
Semaglutide and alcohol: what is actually documented Started this topic · Compounds › Semaglutide · 24 Apr 2026 · 0 likes Posting this under the heading it deserves: Semaglutide and alcohol: what is actually documented Everything below is what sits behind that. I would like to know what…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #39 · Evidence › Journal club · 24 Apr 2026 · 13 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
[2026 update] What a purity-only report leaves out Replied, post #102 · Sourcing › Independent verification · 24 Apr 2026 · 19 likes Coming back to post #100, because the follow-up matters more than the original answer. It does not extend to lots nobody has seen, it is not a recommendation, and it…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #66 · Practice › Reconstitution · 22 Apr 2026 · 31 likes Adding the measurement that post #65 says would settle it. Two people can reconstitute the same vial to different concentrations and both be right. The dose is the…
-
Tracking intake honestly when appetite is absent Started this topic · Nutrition & Training › Protein & intake · 13 Apr 2026 · 0 likes On the subject in the title: Tracking intake honestly when appetite is absent Working notes rather than a conclusion. I have spent a fortnight trying to pin tracking…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #57 · Evidence › Trials · 5 Apr 2026 · 1 like I had written a reply contradicting post #54 and deleted it. Here is what survived. Whatever the answer on Composite endpoints turns out to be, the method for getting…
-
Blind submission and why it changes minds — the long version Replied, post #8 · Sourcing › Independent verification · 3 Apr 2026 · 23 likes An honest declaration on Blind submission: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #49 · Clinical › Comorbidities · 30 Mar 2026 · 11 likes Confirming post #48 from a second method, which matters more than confirming it from a second person. The practical value of this subcategory is helping somebody frame…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #27 · Analytics › COA interpretation · 29 Mar 2026 · 4 likes Post #23 describes the usual case. This is about the unusual one. Distinguishing three things in the Reused chromatograms across lots discussion that keep getting used…
-
The headache that turns out to be dehydration — the long version Replied, post #11 · Nutrition & Training › Hydration & electrolytes · 19 Mar 2026 · 19 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. Reading it back, the second half matters…
-
Amylin receptor signalling and satiety — what changed since Replied, post #47 · Pharmacology › Receptor biology · 19 Mar 2026 · 26 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #18 · Analytics › HPLC & UHPLC · 14 Mar 2026 · 0 likes Building on post #15 rather than restating it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the…
-
A single out-of-range value on an otherwise normal panel Replied, post #21 · Clinical › Bloodwork · 8 Mar 2026 · 4 likes Picking up post #18: that is the part I would want checked first. An update on my earlier single out-of-range value post: the pattern held for another six weeks and…
-
Second pass at: Identical chromatograms across two different lots Replied, post #36 · Sourcing › Red flags · 1 Mar 2026 · 1 like Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #60 · Outcomes › Body composition · 27 Feb 2026 · 4 likes An update on my earlier Circumference measurements post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #6 · Pharmacology › Formulation chemistry · 27 Feb 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Lyophilisation, because it is the sort of subject where it matters.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #132 · Access › International · 26 Feb 2026 · 6 likes Bookmarking this. I will come back when I have something worth adding.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #13 · Evidence › Trials · 26 Feb 2026 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Journal club: LEADER as the historical anchor Replied, post #39 · Evidence › Journal club · 25 Feb 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. That is where I…
-
Managing an unplanned gap in supply Replied, post #40 · Access › Shortages · 23 Feb 2026 · 18 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Forced degradation studies: designing one that is informative Replied, post #10 · Analytics › Method validation · 22 Feb 2026 · 30 likes Post #6 describes the usual case. This is about the unusual one. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
Preprint servers and what screening they do Replied, post #63 · Evidence › Preprints · 21 Feb 2026 · 0 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. Flagging that the…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #53 · Analytics › Impurities & related substances · 17 Feb 2026 · 11 likes If you are new and reading this thread for the answer to rising related-substance: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #2 · Evidence › Trials · 11 Feb 2026 · 7 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #6 · marked as the solution · Analytics › Impurities & related substances · 9 Feb 2026 · 32 likes This follows post #3 rather than contradicting it. Adding what did not work for me on Residual solvents and scavengers, since the failures never get written up and they…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #29 · Evidence › Trials · 6 Feb 2026 · 0 likes Summarising the Reading a supplementary appendix thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #23 · Sourcing › Independent verification · 2 Feb 2026 · 17 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. For what it is worth, the same…
-
Second pass at: What pooling buys you and what it destroys Replied, post #12 · Evidence › Meta-analyses · 24 Jan 2026 · 33 likes Speaking only to pooling buys as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #67 · Regional › UK & Ireland · 14 Jan 2026 · 0 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #7 · Practice › Storage & stability · 24 Dec 2025 · 0 likes Post #4 is the version of this I will quote in future. One addition. The version of peptide that circulates here is a simplification of a simplification. It is not…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #23 · Pharmacology › Receptor biology · 22 Dec 2025 · 24 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #16 · Practice › Interactions · 9 Dec 2025 · 4 likes Taking post #15 at face value and following it one step further. I changed my mind about Metformin co-administration after someone here asked me for the source and I…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #30 · Access › Pricing · 5 Dec 2025 · 0 likes Narrowing post #29, because the general version has more than one answer. Price changes is one of those subjects where the general answer and the answer for a specific…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #103 · Documentation › Doc review · 30 Nov 2025 · 3 likes The honest answer on Promotion criteria is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #37 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Sequence verification is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
[2026 update] What steady state means for the decision to escalate Replied, post #76 · Practice › Dosing & titration · 13 Nov 2025 · 7 likes Worth separating two things that post #72 runs together. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives.…
-
Constipation management, with a dietitian's contribution Started this topic · Practice › Side effects · 4 Nov 2025 · 5 likes Posting this under the heading it deserves: Constipation management, with a dietitian's contribution Everything below is what sits behind that. Constipation management:…
-
Pooling trials with different estimands — what changed since Replied, post #46 · Evidence › Meta-analyses · 4 Nov 2025 · 7 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #89 · Practice › Reconstitution · 31 Oct 2025 · 1 like Post #87 is the version of this I will quote in future. One addition. Reading this decimal-point error thread as someone who came in with a fixed view: the third and…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #11 · Practice › Side effects · 28 Oct 2025 · 9 likes Taking post #9 at face value and following it one step further. I would keep Dizziness on standing and the decision it usually gets used for separate in this thread.…
-
Publishing an inconvenient result: a case study — the long version Replied, post #17 · Sourcing › Independent verification · 24 Oct 2025 · 1 like Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies are explained by handling or method and asking costs a day.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #22 · Safety › Adverse events · 15 Oct 2025 · 8 likes A report is more useful with dates, dose, timing relative to dose, and everything else being taken. Without those it cannot be assessed.
-
A comparison of home results against a laboratory result on the same vial Replied, post #37 · Analytics › Home & field testing · 15 Sep 2025 · 3 likes Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #52 · Practice › Dosing & titration · 14 Sep 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Reading an interaction checker output critically Replied, post #4 · Practice › Interactions · 11 Sep 2025 · 0 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist. Filing…
-
System suitability injections: if they failed, the run did not happen Replied, post #25 · Analytics › HPLC & UHPLC · 23 Aug 2025 · 31 likes Fair, and the limits you put on it are the part I will remember.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #83 · Data & Tools › Calculators · 15 Aug 2025 · 6 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Request: a diff view for wiki revisions — the long version Replied, post #29 · Meta › Feature requests · 11 Aug 2025 · 3 likes Adding a data point of agreement rather than a data point.
-
Publishing an inconvenient result: a case study Replied, post #58 · Sourcing › Independent verification · 31 Jul 2025 · 13 likes Post #55 is the version of this I will quote in future. One addition. Something worth flagging about publishing an inconvenient result: the strongest-sounding claims in…
-
When to stop reading forums, including this one Replied, post #10 · Wellbeing › Mental health · 29 Jul 2025 · 4 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #17 · Sourcing › Vendor reports · 26 Jun 2025 · 28 likes Post #15 and I disagree about the size of the effect, not about the direction. Where you have no independent result, a documentation report is still worth filing: what…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #74 · Clinical › Comorbidities · 25 Jun 2025 · 0 likes What I would check first on hepatic steatosis is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Follow-up: Requesting a page: what makes a good request Replied, post #47 · Documentation › Wiki requests · 11 Jun 2025 · 1 like Link the topics that prompted the request. The discussion is the evidence that the question recurs. A modest claim, modestly supported.
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #15 · Evidence › Trials · 5 Jun 2025 · 29 likes Post #14 put the caveat in the right place and I want to underline it. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
Coming back to: Getting a referral rather than a refusal Replied, post #33 · Clinical › Prescriber conversations · 5 Jun 2025 · 0 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Follow-up: What other technical communities get right that we do not Replied, post #118 · Lounge › Off topic · 2 Jun 2025 · 10 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Follow-up: What other technical communities get right that we do not Replied, post #107 · Lounge › Off topic · 23 May 2025 · 23 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors. I looked this up rather than remembered it, which is the right…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #41 · Clinical › Comorbidities · 16 May 2025 · 0 likes Worth separating two things that post #37 runs together. Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #112 · Compounds › Cagrilintide & amylin analogues · 9 May 2025 · 12 likes Post #111 answers the question as asked. The question underneath it is different. Amylin analogues affect gastric emptying as well, so the mechanism overlaps the…
-
Micronutrient status when intake falls substantially Replied, post #4 · Clinical › Bloodwork · 8 May 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #12 · Outcomes › Body composition · 7 May 2025 · 1 like The arithmetic in post #11 is right; the assumption feeding it is the part to check. Comparing a body composition result against a population reference is a different…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #11 · Practice › Dosing & titration · 21 Apr 2025 · 28 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Coverage for the indication versus for the drug Replied, post #36 · Access › Insurance & coverage · 20 Apr 2025 · 3 likes Post #33 and I disagree about the size of the effect, not about the direction. The useful distinction on coverage is between what was measured and what was inferred…
-
Review cadence: how often is a page actually re-checked? Replied, post #16 · Documentation › Doc review · 11 Apr 2025 · 27 likes Reading rather than answering, but this is the post I would point somebody at.
-
Retatrutide dose escalation in the published trials Replied, post #115 · Compounds › Retatrutide · 10 Apr 2025 · 14 likes Before the thread moves on from retatrutide dose escalation — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
-
A promotion I argued against, and why I lost Replied, post #149 · Documentation › Doc review · 27 Mar 2025 · 1 like Sensible. I would want the same detail before I acted on it either.
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #10 · Analytics › Mass spectrometry · 21 Mar 2025 · 30 likes Coming back to post #8, because the follow-up matters more than the original answer. What mass accuracy establishes: the measured mass is consistent with a specific…
-
Charge states for a 4 kDa peptide, worked through Replied, post #147 · Analytics › Mass spectrometry · 18 Mar 2025 · 0 likes Where I part company with post #143, and it is a narrow parting. I would call the community position on charge states likely rather than established, and I would be…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #86 · Sourcing › Regulatory · 3 Mar 2025 · 26 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #50 · Evidence › Journal club · 3 Mar 2025 · 6 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Coming back to: Official shortage notices and what they authorise Replied, post #27 · Access › Shortages · 19 Feb 2025 · 5 likes I read post #23 twice before replying, because I had assumed the opposite. Shortages end and the notices are updated. Checking the current notice takes a minute and is…
-
A promotion I argued against, and why I lost Replied, post #86 · Documentation › Doc review · 5 Feb 2025 · 1 like I keep a log for promotion specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #2 · Documentation › Doc review · 24 Jan 2025 · 14 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Objections are genuinely wanted at this stage, because a…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #152 · Clinical › Prescriber conversations · 20 Jan 2025 · 28 likes I had written a reply contradicting post #150 and deleted it. Here is what survived. Bringing a record of symptoms with dates and severities makes an assessment…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #97 · Evidence › Journal club · 19 Jan 2025 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #19 · Evidence › Meta-analyses · 15 Jan 2025 · 0 likes Subgroup meta-analysis multiplies the usual subgroup problems by the number of included trials. Treat it as hypothesis-generating without exception. That distinction…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #119 · Access › Insurance & coverage · 13 Jan 2025 · 0 likes An honest declaration on Step therapy requirements: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #25 · Compounds › Secretagogues & GH axis · 10 Jan 2025 · 0 likes Agreed on well-designed human trial, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
Follow-up: Individual participant data versus aggregate data Replied, post #67 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Turnaround times and what they mean for a decision — one year on Replied, post #25 · Sourcing › Independent verification · 28 Dec 2024 · 6 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Building a sensible monitoring schedule with your prescriber Replied, post #101 · Clinical › Bloodwork · 23 Dec 2024 · 3 likes I would keep building a sensible monitoring schedule and the decision it usually gets used for separate in this thread. They are related and they are not the same…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #62 · Compounds › Tirzepatide · 30 Nov 2024 · 0 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #4 · Devices › Syringes & needles · 24 Nov 2024 · 0 likes Post #2 describes the usual case. This is about the unusual one. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #23 · Practice › Reconstitution · 23 Nov 2024 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #105 · Clinical › Prescriber conversations · 21 Nov 2024 · 21 likes Answering the question post #101 raises rather than the one it answers. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #35 · Access › Insurance & coverage · 21 Nov 2024 · 1 like Taking post #32 at face value and following it one step further. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking…
-
When "no data" is the complete and final answer Replied, post #23 · Compounds › Other compounds · 18 Nov 2024 · 0 likes Adding a data point of agreement rather than a data point.
-
EMA product information as a primary source — does this still hold? Replied, post #108 · Regional › European Union · 18 Nov 2024 · 5 likes France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
-
When to suspect the method rather than the sample Replied, post #28 · Analytics › Method validation · 25 Oct 2024 · 26 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #15 · Clinical › Comorbidities · 2 Oct 2024 · 6 likes Adding the measurement that post #14 says would settle it. Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #94 · Sourcing › Independent verification · 29 Sep 2024 · 2 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #48 · Evidence › Journal club · 19 Sep 2024 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
The topic list is dense — is that deliberate? Replied, post #23 · Meta › Site feedback · 8 Sep 2024 · 0 likes Taking post #22 at face value and following it one step further. Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #6 · Clinical › Bloodwork · 2 Sep 2024 · 6 likes I came in to disagree and I am leaving without a disagreement.
-
Chronic kidney disease and the FLOW result Replied, post #15 · Clinical › Comorbidities · 14 Aug 2024 · 15 likes Chronic kidney disease looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.